XML 57 R35.htm IDEA: XBRL DOCUMENT v3.20.4
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2020
Stock-Based Compensation  
Schedule of stock-based compensation expense

Total compensation cost recognized for all stock-based compensation awards in the consolidated statements of operations was as follows (in thousands):

    

    

Year Ended

December 31, 

2020

2019

Research and development

$

11,580

$

13,538

General and administrative

 

11,576

 

13,705

Total stock-based compensation expense

$

23,156

$

27,243

Schedule of changes in unvested restricted stock

    

    

Weighted

Average

Grant Date

Fair Value

Shares

Per Share

Unvested restricted stock and restricted stock unit awards as of December 31, 2019

 

581,408

$

24.03

Issued

 

364,549

$

29.57

Vested

 

(304,638)

$

23.37

Forfeited

(133,869)

$

24.72

Unvested restricted stock and restricted stock unit awards as of December 31, 2020

 

507,450

$

27.35

Schedule of stock option activity

    

    

Weighted Average

    

Remaining

    

Aggregate Intrinsic

Shares

Exercise Price

Contractual Life (years)

Value (in thousands)

Outstanding at December 31, 2019

 

4,358,291

$

25.40

7.4

$

26,060

Granted

1,721,748

$

30.44

Exercised

(964,412)

$

20.22

Cancelled

(1,203,370)

$

30.72

Outstanding at December 31, 2020

 

3,912,257

$

27.26

7.9

$

167,640

Exercisable at December 31, 2020

 

1,463,668

$

24.05

6.8

$

67,413

Schedule of assumptions used to value stock options

    

Year Ended

December 31, 

2020

2019

    

2018

Expected volatility

 

60.0

%  

73.8

%  

77.5

%  

Expected option term (in years)

 

6.25

6.25

6.25

Risk free interest rate

 

1.5

%  

2.0

%  

2.9

%  

Expected dividend yield